VICTOR HONG: Open Payments
NPI 1134155401 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,171 in 94 payments from 20 companies in 2025. Trend: 2023 $1,733 · 2024 $1,975 · 2025 $2,171
Food & beverage: $2,171
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $350 |
| Neurocrine BioSciences, Inc. | 13 | $277 |
| Vanda Pharmaceuticals Inc. | 6 | $255 |
| E.R. Squibb & Sons, L.L.C. | 4 | $176 |
| Collegium Pharmaceutical, Inc. | 3 | $163 |
| Alkermes, Inc. | 5 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Teva Pharmaceuticals USA, Inc. | 5 | $82 |
| ABBVIE INC. | 4 | $80 |
Products named: REXULTI, INGREZZA, COBENFY, Jornay PM, FANAPT, CAPLYTA, HETLIOZ, Auvelity.
Industry payments across FL — which companies pay providers there.
